South Korea: national COVID-19 vaccination rate by age 2023

As of August 28, 2023, South Koreans in their twenties had the highest coronavirus (COVID-19) vaccination rate in South Korea for the initial two shots, at 99.8 percent and 98.9 percent respectively. All adult age groups reported very high vaccination rates. Winter booster shot rates however were much lower across all age groups, though older age groups were more likely to have gotten them. Only around 13 percent of people nationwide have been vaccinated with a bivalent winter booster, which is more effective against current dominant strains. These shots were only offered in the winter of 2022.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

National coronavirus (COVID-19) vaccination rate in South Korea as of August 28, 2023, by age group

Characteristic	First shot	Second shot	Winter booster shots*
0-4 years	0.1%	0.1%	0%
5-11 years	1.5%	1.2%	0%
12-17 years	55%	52.6%	1.1%
18-19 years	91.7%	90.1%	4%
20-29 years	99.8%	98.9%	6.2%
30-39 years	97.9%	96.6%	4.7%
40-49 years	96.5%	95.6%	5.2%
50-59 years	98.4%	97.9%	9%
60-69 years	98.5%	98.1%	24.9%
70-79 years	97.2%	96.8%	42%
80+ years	93.5%	92.9%	43.9%
Total	87.45%	86.65%	12.95%

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

August 2023

More information

Region

South Korea

Survey time period

August 28, 2023

Supplementary notes

* Winter shots were discontinued from April 7, 2023.

So-called "winter shots" were initially introduced as another booster in addition to the first and second booster shots (overall the fourth and fifth shots respectively) to preemptively prepare for an anticipation rise in cases during the winter of 2022. As of December 2022, booster shots were discontinued, and any additional shots beyond the first two were merged into the winter shot category to avoid confusion. Winter shots, unlike the previous boosters, use bivalent vaccines, which are more effective against current strains dominating South Korea.

Citation formats